To the Shareholders and Shareholder Representatives:
Shanxi Hualian Group Co., Ltd. 2025 Independent Director Performance Report (Wang Jun)
As an independent director of Shanxi Hualian Group Co., Ltd. (hereinafter referred to as the "Company"), I have, in accordance with the "Company Law of the People's Republic of China," "Securities Law of the People's Republic of China," "Shenzhen Stock Exchange Main Board Listed Company Self-Regulatory Guidelines No. 1 - Norms for Operations of Listed Companies on the Main Board," "Measures for Independent Directors of Listed Companies," and other laws and regulations, as well as the "Articles of Association" and the "Independent Director Work System," diligently performed my duties during the 2025 fiscal year. I independently, cautiously, and conscientiously exercised the rights granted to me by the Company, promptly understood the Company's operating status, actively attended relevant meetings convened by the Company and dedicated meetings of independent directors, diligently reviewed various proposals, fully utilized the role of independent directors and members of various special committees, and effectively protected the legitimate rights and interests of the Company and all shareholders, especially public shareholders. Herein is my performance report for 2025:
I. Basic Information of Independent Director
(I) Basic Information Wang Jun, male, born in 1966, Chinese national, with no permanent residency abroad, holds a bachelor's degree and is a senior lawyer. He previously served as an independent director of Shanxi Tongde Chemical Co., Ltd. and Jingying Shuzhi Technology Co., Ltd. He currently serves as an arbitrator for the Taiyuan Arbitration Commission, a lawyer and partner at Shanxi Baoyang Law Firm, and an independent director of the Company.
(II) Explanation of Circumstances Affecting Independence As an independent director of the Company, after self-examination, I confirm that I meet the relevant requirements for the independence of independent directors stipulated in the "Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Main Board Listed Company Self-Regulatory Guidelines No. 1 - Norms for Operations of Listed Companies on the Main Board," and other relevant laws and regulations. There are no circumstances affecting my independence.
II. Annual Performance of Independent Director
(I) Attendance at Board and Shareholder Meetings In 2025, the Company's Board of Directors convened 8 meetings, all of which were held through a combination of on-site and written voting. My attendance as an independent director of the Fifth Board of Directors is as follows:
| Independent Director Name | Number of Board Meetings to Attend | Number of On-site Attendance | Number of Attendance via Communication | Number of Entrusted Attendance | Number of Absences | Whether Absent from Two Consecutive Board Meetings |
|---|---|---|---|---|---|---|
| Wang Jun | 2 | 2 | 1 | 0 | 0 | No |
During 2025, I diligently and pragmatically reviewed all proposals submitted to the Board of Directors. I engaged in discussions with directors, the Company Secretary, and securities affairs representatives from a professional perspective, offering suggestions and exercising my voting rights independently and prudently. I believe that the convening and holding of the Company's Board of Directors met statutory procedures, and major operational matters underwent relevant approval procedures, making them legal and effective. Therefore, I voted in favor of all proposals and other matters of the Company in 2025, with no dissenting opinions, objections, or abstentions. During the reporting period, the Company did not convene any shareholder meetings.